Tracking progress of the development of Ataxia therapies.
Treatment development is a long process that involves multiple phases of a clinical trial and oversight by the Food and Drug Administration (FDA). NAF is committed to empowering you with up-to-date information about Ataxia treatment development. The pipelines are visual tools that were created to show the progress of all Ataxia therapies that are currently being developed. There is a pipeline for each type of Ataxia that currently has therapies in development.